subcutaneous drug delivery

After winning full FDA nod for Leqembi, Eisai touts 'promising' study on subcutaneous version
Fierce Pharma
Thu, 07/20/23 - 10:09 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
subcutaneous drug delivery
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech
Fierce Biotech
Tue, 03/29/22 - 10:36 am
Roche
Chugai
drug delivery
subcutaneous drug delivery
Haolzyme Therapeutics
Enhanze